Biblio

Export 795 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Humans  [Clear All Filters]
2022
K. A. Josephs, Pham, N. Trang Thu, Graff-Radford, J., Machulda, M. M., Lowe, V. J., and Whitwell, J. L., “Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.”, J Alzheimers Dis, vol. 86, no. 1, pp. 491-498, 2022.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., “Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project.”, J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
L. Wang, Chen, H., Tang, J., Guo, Z., and Wang, Y., “Peptidylarginine Deiminase and Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
Y. - Y. Huang, Chen, S. - D., Leng, X. - Y., Kuo, K., Wang, Z. - T., Cui, M., Tan, L., Wang, K., Dong, Q., and Yu, J. - T., “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., “Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
A. Crestini, Santilli, F., Martellucci, S., Carbone, E., Sorice, M., Piscopo, P., and Mattei, V., “Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 503-518, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
E. Marina Gon Cordero, Cuevas-Budhart, M. Angel, Morán, D. Pérez, Villeda, M. Angel Trej, and Gª-Madrid, M. Gomez- Del-, “Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 87, no. 2, pp. 519-528, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., “Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., “Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.”, J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., “Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
J. Lynn, Park, M., Ogunwale, C., and Acquaah-Mensah, G. K., “A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
K. Metsla, Kirss, S., Laks, K., Sildnik, G., Palgi, M., Palumaa, T., Tõugu, V., and Palumaa, P., “α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 715-728, 2022.
2021
R. Gil and Arroyo-Anlló, E. M., “Alzheimer's Disease and Face Masks in Times of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
J. Bastrup, Hansen, K. H., Poulsen, T. B. G., Kastaniegaard, K., Asuni, A. A., Christensen, S., Belling, D., Helboe, L., Stensballe, A., and Volbracht, C., “Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 1, pp. 249-265, 2021.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., “APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
A. Lladó, Froelich, L., Khandker, R. K., Roset, M., Black, C. M., Lara, N., Chekani, F., and Ambegaonkar, B. M., “Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.”, J Alzheimers Dis, vol. 80, no. 2, pp. 749-759, 2021.
C. Themistocleous, Ficek, B., Webster, K., Ouden, D. - Bden, Hillis, A. E., and Tsapkini, K., “Automatic Subtyping of Individuals with Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. Mulak, “Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 2, pp. 461-477, 2021.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., “Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.

Pages